2003

Nov 19, 2003
Guidant Updates Investors During Annual Investor/Analyst Conference in New York

Company Reiterates Guidance for 2003; Previews 2004 Full-Year Revenue and Earnings New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will...

Nov 19, 2003
Guidant Broadens Advanced Patient Management Initiative with CardioMEMS Investment

New Investments and Sponsorships Bolster Guidant''s Commitment to Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Nov 18, 2003
GE and Guidant Announce Unique Long-Term Relationship to Enhance and Improve Cardiovascular Patient Care

Strategic alliance allows for sharing of data and systems Milwaukee, Wis. and St. Paul, Minn. - GE Medical Systems, a division of the General Electric Company (NYSE: GE) and Guidant Corporation...

Nov 11, 2003
Guidant Announces U.S. Approval and Market Release of Novel Defibrillation Lead Family

RELIANCE G Leads are First to Feature Covering to Prevent Tissue Ingrowth Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Nov 10, 2003
Guidant Receives U.S. Approval of Most Advanced Pacemaker

NSIGNIA Ultra''s Unique Technology Enables Tailored Therapy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 9, 2003
Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment

MADIT II patients with heart failure now eligible for Cardiac Resynchronization Therapy Defibrillator Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the...

Nov 9, 2003
Guidant Announces Exclusive Sponsorship of MADIT-CRT Clinical Trial

Guidant''s Leadership in Heart Failure Therapy Continues with Landmark Study Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Nov 7, 2003
Guidant Announces Live Webcast of its Annual Investor/Analyst Conference

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...

Oct 22, 2003
Guidant Announces U.S. Launch of Implantable Defibrillator Offering Optimal Combination of Size and Longevity

Latest Defibrillator Expands Successful Product Portfolio Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 21, 2003
Guidant Announces Fourth Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a fourth...

Oct 21, 2003
Guidant Licenses Innovative Tissue-Welding Technology for Cardiac Surgery

Agreement Reinforces Guidant''s Leadership in Endoscopic Cardiovascular Technologies Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Oct 16, 2003
Guidant Reports Record Third Quarter Sales of $938 million, 15 Percent Sales Growth

* Worldwide implantable defibrillator revenue of $385 million, up 48 percent * Worldwide stent revenue of $200 million, down 14 percent * Gross margin increases to 76.1 percent * Drug eluting...

Oct 9, 2003
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2003 earnings conference...

Oct 8, 2003
Guidant Initiates Voluntary Recall of 3.0 mm-Diameter MULTI-LINK VISION Coronary Stent System

Company Resumes Product Shipment with Food and Drug Administration Approval Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 6, 2003
Guidant Announces European Approval and First Implant of Next Generation Heart Failure Therapy System

Cardiac Resynchronization Therapy Defibrillator Represents the World''s Thinnest, Most Advanced System Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in...

Oct 2, 2003
Guidant Appoints Beverly H. Lorell, M.D., Vice President, Chief Medical and Technology Officer

New Position Will Lead Technology Development Strategy INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Beverly...

Sep 23, 2003
COMPANION Trial Results to be Announced During Late Breaking Scientific Session at the Heart Failure Society of America 7th Annual Scientific Meeting

Updated Landmark Heart Failure Trial Data Submitted to Peer-Reviewed Journal LAS VEGAS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 23, 2003
Guidant Completes Enrollment in Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world...

Sep 19, 2003
Guidant's Institute for Therapy Advancement Europe Welcomes 5,000th Participant

Institute Demonstrates Guidant''s Leadership in Medical Education Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 18, 2003
David E. Kandzari, M.D., Wins First Annual Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Sep 18, 2003
Guidant Announces Additional Findings of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Study Shows Correlation Between Lipid-Rich Plaques and Heart Attacks in Cath Lab Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Sep 17, 2003
Guidant Reports Positive Results of Two Everolimus Eluting Coronary Stent Clinical Trials

FUTURE I and II Trials Utilize Everolimus with Bioabsorbable Polymer; Results Presented Today Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Sep 11, 2003
Guidant to Host Investor Briefing at Transcatheter Cardiovascular Therapeutics Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Sep 4, 2003
Guidant to Participate in Bear Stearns 16th Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Sep 2, 2003
Guidant Acquires Innovative Polymer Technology for Drug Eluting Stent Program

"Programmable" Polymer Capabilities Strengthen Guidant''s Development of Future Therapies for Coronary Artery Disease Indianapolis and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a...

Show 5102550100 per page
Top